Mubadala Plans Purchase Of Bridgepoint's $2.5 Bln Dialysis Firm Diaverum - Bloomberg News
PARIS, France - Abu Dhabi's second - biggest sovereign wealth fund Mubadala Investment Co is exploring the purchase of Bridgepoint Group Plc's European dialysis clinic chain Diaverum for about $2.5 billion, Bloomberg News reported on Thursday.
The Abu Dhabi fund is among final bidders competing to buy Sweden-based Diaverum from the British private investment firm, the report said citing people familiar with the matter.
Diaverum, founded in 1991, is a multi-national firm which provides renal care and operates 440 clinics in 23 countries.
Mubadala's chief said in December that 2023 would be a tough year for the global economy, but the fund would be focused on opportunities serving a longer horizon.
The fund, which invest in a diverse portfolio ranging from energy to healthcare and real estate to technology, has $284 billion in assets under management, according to its website.